Publications by authors named "N Alattar"
Article Synopsis
- Sternal non-union is a rare complication after cardiac surgery that involves prolonged sternal pain and instability, typically lasting over six months without infection, and is confirmed via CT scans.
- The study reports on seven patients who underwent surgery for sternal non-union between 2015 and 2020, using a method involving sternal edge debridement, plate fixation, and autologous iliac crest bone grafting to stabilize the sternum.
- The patient demographics indicated a median age of 65, with risk factors like diabetes and smoking, and while there were some postoperative complications like iliac crest pain, all patients experienced long-term resolution without needing further surgeries.
Article Synopsis
- The study evaluated the short-term outcomes of surgical aortic valve replacement (SAVR) in elderly patients aged 70 and above, comparing those aged 70-79 years with those aged 80 and older.
- Both age groups showed similar survival rates at 30 days and 1 year post-SAVR, indicating that age alone does not predict poorer outcomes.
- Risk factors for higher mortality included insulin-dependent diabetes and severe heart failure (NYHA class IV), which should be carefully considered when selecting elderly patients for SAVR.
Aims: Many historical and recent reports showed that post-infarction ventricular septal rupture (VSR) represents a life-threatening condition and the strategy to optimally manage it remains undefined. Therefore, disparate treatment policies among different centres with variable results are often described. We analysed data from European centres to capture the current clinical practice in VSR management.
View Article and Find Full Text PDFBackground: Previous studies comparing percutaneous coronary intervention (PCI) with coronary artery bypass grafting (CABG) in patients with multivessel coronary disease not involving the left main have shown significantly lower rates of death, myocardial infarction (MI), or stroke after CABG. These studies did not routinely use current-generation drug-eluting stents or fractional flow reserve (FFR) to guide PCI.
Methods: FAME 3 (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) is an investigator-initiated, multicenter, international, randomized trial involving patients with 3-vessel coronary artery disease (not involving the left main coronary artery) in 48 centers worldwide.
This postmarket clinical study evaluated the safety and effectiveness of the novel adjunctive topical hemostat SURGICEL® Powder (SURGICEL®-P), a powdered form of oxidized regenerated cellulose. In a prospective, open-label, single-arm multicenter trial, adult surgical subjects with mild-to-moderate bleeding for which conventional hemostatic methods were impractical/ineffective were treated with SURGICEL®-P. Descriptive analyses included hemostatic success rate at 3, 5, and 10 min, rebleeding and thromboembolic events, SURGICEL®-P-related serious adverse events requiring surgical intervention, and SURGICEL®-P ease of use (questionnaire).
View Article and Find Full Text PDF